Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
Crossref DOI link: https://doi.org/10.1038/s41598-023-42878-5
Published Online: 2023-09-22
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Arav, Yehuda
Zohar, Assaf
Text and Data Mining valid from 2023-09-22
Version of Record valid from 2023-09-22
Article History
Received: 6 April 2023
Accepted: 15 September 2023
First Online: 22 September 2023
Competing interests
: The authors declare no competing interests.